manilatimes9h
AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza
Paul Goepfert, MD, Director for the Alabama Vaccine Research Clinic, stated: "I'm excited for the opportunity to follow-up on ...
AIM announces principal investigator for Ampligen, FluMist clinical study
AIM ImmunoTech (AIM) announced that Paul Goepfert, MD, of the University of Alabama-Birmingham, has agreed to act as the Principal Investigator ...
New Republic1dOpinion
Trump Takes Aim at Social Security in Dreadful New Layoffs Order
The sticker-shock warning came amid the unveiling of a new plan by the Trump administration to alleviate egg prices, which ...
Hosted on MSN1d
AIM Vaccine s mRNA RSV Vaccine Approved for U S Clinical Trials
Innovation and Global Expansion Attract Capital Reassessment AIM Vaccine Co., Ltd. (a joint stock company incorporated in the People's Republic of China with limited liability) (Stock Code: 6660.HK) ...
Trump Aims at Chinese Shipping, Risking Another Shock for Businesses
A new proposal would impose steep levies on Chinese-made ships arriving at U.S. ports, threatening to increase costs for ...
Vietnam Investment Review on MSN3d
AIM Vaccine s mRNA Shingles Vaccine Submits Clinical Application to the U S
Another Step Forward in Global Expansion HONG KONG, Feb. 25, 2025 /PRNewswire/ -- As global capital reassesses the investment value of innovative Chinese companies, the development of innovative ...